Flora Growth Corp. Announces 1-for-39 Share Consolidation
Flora Growth Corp. (NASDAQ: FLGC) has announced a 1-for-39 share consolidation of its issued and outstanding common shares, effective August 3, 2025. The consolidation aims to increase the bid price of common shares to regain compliance with Nasdaq Capital Market listing requirements.
Trading on a post-consolidation basis will begin on August 4, 2025. For every 39 existing shares, shareholders will receive one new share, with fractional shares rounded up to the next whole share. The stock will continue trading under the ticker "FLGC" with a new CUSIP number 339764300.
The consolidation was approved by shareholders on June 30, 2025, authorizing a ratio range of 1-for-10 up to 1-for-100. No action is required from shareholders holding shares electronically or through brokers.
Flora Growth Corp. (NASDAQ: FLGC) ha annunciato una consolidazione azionaria 1-per-39 delle sue azioni ordinarie emesse e in circolazione, con effetto dal 3 agosto 2025. L'operazione mira ad aumentare il prezzo di offerta delle azioni ordinarie per riconquistare la conformit脿 ai requisiti di quotazione del Nasdaq Capital Market.
Le negoziazioni basate sulle azioni consolidate inizieranno il 4 agosto 2025. Per ogni 39 azioni esistenti, gli azionisti riceveranno una nuova azione, con le frazioni arrotondate per eccesso alla azione intera successiva. Le azioni continueranno a essere negoziate con il ticker "FLGC" e un nuovo numero CUSIP 339764300.
La consolidazione 猫 stata approvata dagli azionisti il 30 giugno 2025, autorizzando un rapporto variabile da 1-per-10 fino a 1-per-100. Non 猫 richiesta alcuna azione da parte degli azionisti che detengono azioni in forma elettronica o tramite broker.
Flora Growth Corp. (NASDAQ: FLGC) ha anunciado una consolidaci贸n de acciones 1 por 39 de sus acciones ordinarias emitidas y en circulaci贸n, con efecto a partir del 3 de agosto de 2025. Esta consolidaci贸n tiene como objetivo aumentar el precio de oferta de las acciones ordinarias para cumplir nuevamente con los requisitos de cotizaci贸n del Nasdaq Capital Market.
La negociaci贸n basada en la consolidaci贸n comenzar谩 el 4 de agosto de 2025. Por cada 39 acciones existentes, los accionistas recibir谩n una nueva acci贸n, redondeando hacia arriba las fracciones a la acci贸n entera siguiente. Las acciones seguir谩n cotizando bajo el s铆mbolo "FLGC" con un nuevo n煤mero CUSIP 339764300.
La consolidaci贸n fue aprobada por los accionistas el 30 de junio de 2025, autorizando un rango de proporci贸n de 1 por 10 hasta 1 por 100. No se requiere ninguna acci贸n por parte de los accionistas que posean acciones electr贸nicamente o a trav茅s de corredores.
Flora Growth Corp. (NASDAQ: FLGC)電� 2025雲� 8鞗� 3鞚茧秬搿� 氚滍枆 氚� 鞙犿喌 欷戩澑 氤错喌欤检棎 雽�頃� 1欤茧嫻 39欤� 氤戫暕鞚� 氚滍憸頄堨姷雼堧嫟. 鞚措矆 氤戫暕鞚� 氤错喌欤检潣 毵れ垬臧�毳� 雴掛棳 雮橃姢雼� 旌愴敿韯� 毵堨紦 靸侅灔 鞖旉贝鞚� 雼れ嫓 於╈”頃橁赴 鞙勴暅 氇╈爜鞛呺媹雼�.
氤戫暕 頉� 瓯半灅電� 2025雲� 8鞗� 4鞚�攵�韯� 鞁滌瀾霅╇媹雼�. 旮办〈 39欤茧嫻 欤检＜霌れ潃 1欤检潣 靸堧鞖� 欤检嫕鞚� 氚涭溂氅�, 靻岇垬 欤检嫕鞚� 雼れ潓 鞝勳泊 欤检嫕鞙茧 鞓 觳橂Μ霅╇媹雼�. 欤检嫕鞚� "FLGC"霛茧姅 霃欖澕頃� 韹办护搿� 瓿勳啀 瓯半灅霅橂┌, 靸堧鞖� CUSIP 氩堩樃電� 339764300鞛呺媹雼�.
鞚措矆 氤戫暕鞚� 2025雲� 6鞗� 30鞚� 欤检＜霌れ潣 鞀轨澑鞚� 氚涭晿鞙茧┌, 1雽� 10鞐愳劀 1雽� 100旯岇鞚� 牍勳湪 氩旍渼毳� 鞀轨澑氚涭晿鞀惦媹雼�. 鞝勳瀽 氚╈嫕鞚措倶 欷戧皽鞚胳潉 韱淀暣 欤检嫕鞚� 氤挫湢頃� 欤检＜霌れ潃 氤勲弰鞚� 臁办箻毳� 旆暊 頃勳殧臧� 鞐嗢姷雼堧嫟.
Flora Growth Corp. (NASDAQ : FLGC) a annonc茅 une regroupement d'actions au ratio de 1 pour 39 de ses actions ordinaires 茅mises et en circulation, effectif 脿 partir du 3 ao没t 2025. Ce regroupement vise 脿 augmenter le prix des actions ordinaires afin de se conformer de nouveau aux exigences de cotation du Nasdaq Capital Market.
Les transactions bas茅es sur le regroupement commenceront le 4 ao没t 2025. Pour chaque 39 actions existantes, les actionnaires recevront une nouvelle action, les fractions d'actions 茅tant arrondies 脿 l'action enti猫re sup茅rieure. L'action continuera d'锚tre n茅goci茅e sous le symbole "FLGC" avec un nouveau num茅ro CUSIP 339764300.
Le regroupement a 茅t茅 approuv茅 par les actionnaires le 30 juin 2025, autorisant un ratio allant de 1 pour 10 脿 1 pour 100. Aucune action n'est requise de la part des actionnaires d茅tenant des actions 茅lectroniquement ou via des courtiers.
Flora Growth Corp. (NASDAQ: FLGC) hat eine Aktienzusammenlegung im Verh盲ltnis 1 zu 39 seiner ausgegebenen und ausstehenden Stammaktien angek眉ndigt, die am 3. August 2025 wirksam wird. Die Zusammenlegung soll den Kurs der Stammaktien erh枚hen, um die Anforderungen f眉r die Notierung am Nasdaq Capital Market wieder zu erf眉llen.
Der Handel auf Basis der konsolidierten Aktien beginnt am 4. August 2025. F眉r jeweils 39 bestehende Aktien erhalten Aktion盲re eine neue Aktie, wobei Bruchteile auf die n盲chste ganze Aktie aufgerundet werden. Die Aktie wird weiterhin unter dem Tickersymbol "FLGC" mit einer neuen CUSIP-Nummer 339764300 gehandelt.
Die Zusammenlegung wurde am 30. Juni 2025 von den Aktion盲ren genehmigt und erlaubt einen Konsolidierungsverh盲ltnisbereich von 1 zu 10 bis 1 zu 100. Aktion盲re, die ihre Aktien elektronisch oder 眉ber Broker halten, m眉ssen keine Ma脽nahmen ergreifen.
- Potential to regain Nasdaq listing compliance through higher share price
- Automatic rounding up of fractional shares benefits shareholders
- No cash payment required for fractional shares
- Significant share consolidation ratio of 1-for-39 indicates substantial share price decline
- Risk of continued non-compliance with Nasdaq requirements if share price doesn't maintain required levels
Insights
Flora Growth announces a 1-for-39 reverse stock split to regain Nasdaq compliance, a concerning development suggesting significant share price deterioration.
Flora Growth's announcement of a 1-for-39 share consolidation represents a significant defensive maneuver to maintain its Nasdaq listing. The extreme ratio selected鈥攁t the higher end of the previously approved range of 1-for-10 to 1-for-100鈥攕ignals substantial underlying price deterioration that has threatened the company's exchange status. This reverse split is clearly aimed at addressing non-compliance with Nasdaq's minimum bid price requirement of
The mechanics of this consolidation will automatically convert every 39 existing shares into a single new share, mathematically increasing the trading price by the same factor while proportionally reducing the total share count. While this adjustment is purely arithmetic and doesn't fundamentally change the company's market capitalization, enterprise value, or business prospects, the need for such an extreme ratio is concerning.
Historically, companies implementing reverse splits of this magnitude often experience continued selling pressure post-consolidation. This occurs as the higher nominal share price enables institutional investors who couldn't previously exit positions (due to price limitations) to liquidate their holdings more effectively. The fact that Flora opted for a 1-for-39 ratio rather than a more modest adjustment suggests their share price had fallen substantially below Nasdaq's requirements, potentially to the
The company's approach to fractional shares鈥攔ounding up rather than paying cash鈥攊s somewhat shareholder-friendly but represents a minor detail in the overall consolidation. More concerning is the underlying message: Flora's management felt compelled to take this significant step to preserve listing status rather than allowing market fundamentals to naturally support the share price through improved operational performance.
Fort Lauderdale, Florida--(Newsfile Corp. - July 31, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company"), today announced that it will effect a 1-for-39 share consolidation of the Company's issued and outstanding common shares (the "Share Consolidation"). The Share Consolidation will be effective at 5:00 p.m. Eastern Time on August 3, 2025. The Company's common shares (the "Common Shares") are expected to begin trading on The Nasdaq Capital Market on a post-Share Consolidation basis at the open of trading on August 4, 2025.
The Company's shareholders previously approved the Share Consolidation at the annual and special meeting of shareholders held on June 30, 2025 at a ratio ranging from 1-for-10 up to a ratio of 1-for-100, such ratio and the implementation and timing of such Share Consolidation to be determined by the Company's board of directors (the "Board") at its sole discretion, if at all, within one year of the date the proposal is approved by shareholders.
The principal purpose of the Share Consolidation is to increase the bid price of our Common Shares to regain compliance with the continued listing requirements of the Nasdaq Capital Market. The new CUSIP number for the Common Shares is 339764300 and the new ISIN is CA3397643006 as of 5:00 p.m. Eastern Time August 3, 2025. The Common Shares will continue to trade on the Nasdaq Capital Market under the existing ticker "FLGC".
As a result of the Share Consolidation, every 39 Common Shares issued and outstanding will be automatically reclassified into one new Common Share. The Share Consolidation will not modify any rights or preferences of the shares of the Company's Common Shares. Proportionate adjustments will be made to the per share exercise price and the number of Common Shares issuable upon the exercise or conversion of outstanding equity awards, convertible securities and warrants, as well as to the number of Common Shares issued and issuable under the Company's equity incentive plans.
The Common Shares issued pursuant to the Share Consolidation will remain fully paid and non-assessable. The Share Consolidation will not affect the par value of the Common Shares nor will it change the voting power of such holders of our outstanding Common Shares.
No fractional shares will be issued in connection with the Share Consolidation. Shareholders who otherwise would be entitled to receive a fractional share because they hold a number of shares not evenly divisible by the Share Consolidation ratio will automatically be entitled to receive an additional fraction of a Common Share to round up to the next whole share. Cash will not be paid for fractional shares.
Shareholders owning pre-Share Consolidation Common Shares via a bank, broker or other nominee will have their positions automatically adjusted to reflect the Share Consolidation and will not be required to take further action in connection with the Share Consolidation, subject to brokers' particular processes. Similarly, registered shareholders holding pre-Share Consolidation Common Shares electronically in book-entry form are also not required to take further action in connection with the Share Consolidation.
Additional information about the Share Consolidation can be found in the Company's definitive proxy statement filed with the Securities and Exchange Commission (the "SEC") on May 6, 2025, which is available free of charge at the SEC's website, , and on the Company's website at .
Cautionary Statement Regarding Forward-Looking Statements
This press release may contain "forward-looking statements," as defined by U.S. federal securities laws. Forward-looking statements reflect Flora's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," and the negatives of these words and other similar expressions generally identify forward-looking statements. Such forward-looking statements are subject to various and risks and uncertainties, including those described under section entitled "Risk Factors" in Flora's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the "SEC") on March 24, 2025, as such factors may be updated from time to time in Flora's periodic filings with the SEC, which are accessible on the SEC's website at . Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora's filings with the SEC. While forward-looking statements reflect Flora's good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).
Investor Relations:
Investor Relations [email protected]
Clifford Starke [email protected]
Media:
[email protected]
To view the source version of this press release, please visit
FAQ
What is the Flora Growth (FLGC) share consolidation ratio and when is it effective?
Why is Flora Growth (FLGC) implementing a share consolidation?
What happens to fractional shares in the FLGC share consolidation?
Do Flora Growth shareholders need to take any action for the share consolidation?
Will the FLGC stock symbol change after the share consolidation?
